Melt electrowriting is transforming the landscape of tissue engineering discovery and innovation. This advanced 3D printing technique enables the creation of highly precise and customizable microfiber scaffolds at the human cellular scale, opening new frontiers in:
Empowering researchers to regenerate complex tissue structures with unparalleled accuracy.
Enabling groundbreaking studies into tumor growth, metastasis, and targeted treatments.
Revolutionizing how drugs are tested and screened using realistic in-vitro models.
Paul Dalton and colleague Ievgenii Liashenko has launched VivoTex in collaboration with the University of Oregon’s Knight Campus for Accelerating Scientific Impact. This initiative aims to revolutionize biomedical research and tissue engineering. By leveraging MEW’s precision and versatility, the team is set to develop next-generation scaffolds for applications in regenerative medicine, drug discovery, and in-vitro modeling, driving transformative advancements in healthcare and research.
